Baseline characteristics of the cohort showed that patients who developed HCC during surveillance had older age, more male predominance, more cirrhosis, higher proportion of antiviral therapy, poorer hepatic function, higher HBV DNA and higher baseline AFP levels compared to patients who did not develop HCC (Table 1). This evidence concerns the gene AFP and Cirrhosis.